Temat: "Transplantation" - OpacWWW

Starter badań:

Transplantation.

Transplantation antigens are proteins expressed on the surface of an individual’s cells. Every individual has a unique set of these proteins, called human leukocyte antigens (HLAs), which are encoded on chromosome 6. Each parent contributes one HLA-containing chromosome, and both chromosomes are expressed in the offspring. The purpose of these antigens is to help the body recognize what is “self” and what is not. In this manner, bacteria and other pathogens harmful to the individual can... więcej

Magill’s Medical Guide (Online Edition), 2022. 5p.

Skocz do pozycji: 1 1.

Tytuł :: Radiation-sparing reduced-intensity unrelated umbilical cord blood transplantation for rare hematological disorders in children.
Autorzy :: Sawada A; Department of Hematology/Oncology, Osaka Women's and Children's Hospital, 840 Murodo, Izumi city, Osaka, 594-1101, Japan. .
Shimizu M; Department of Hematology/Oncology, Osaka Women's and Children's Hospital, 840 Murodo, Izumi city, Osaka, 594-1101, Japan.
Koyama-Sato M; Department of Hematology/Oncology, Osaka Women's and Children's Hospital, 840 Murodo, Izumi city, Osaka, 594-1101, Japan.
Higuchi K; Department of Hematology/Oncology, Osaka Women's and Children's Hospital, 840 Murodo, Izumi city, Osaka, 594-1101, Japan.
Okada Y; Department of Hematology/Oncology, Osaka Women's and Children's Hospital, 840 Murodo, Izumi city, Osaka, 594-1101, Japan.
Goto K; Department of Hematology/Oncology, Osaka Women's and Children's Hospital, 840 Murodo, Izumi city, Osaka, 594-1101, Japan.
Inoue S; Department of Hematology/Oncology, Osaka Women's and Children's Hospital, 840 Murodo, Izumi city, Osaka, 594-1101, Japan.
Yasui M; Department of Hematology/Oncology, Osaka Women's and Children's Hospital, 840 Murodo, Izumi city, Osaka, 594-1101, Japan.
Inoue M; Department of Hematology/Oncology, Osaka Women's and Children's Hospital, 840 Murodo, Izumi city, Osaka, 594-1101, Japan.; Pokaż więcej
Źródło :: International journal of hematology [Int J Hematol] 2022 Feb; Vol. 115 (2), pp. 269-277. Date of Electronic Publication: 2021 Nov 05.
Typ publikacji :: Journal Article
MeSH Terms :: Cord Blood Stem Cell Transplantation*/adverse effects
Cord Blood Stem Cell Transplantation*/methods
Bone Marrow Failure Disorders/*therapy
Fetal Blood/*transplantation
Leukemia/*therapy
Myelodysplastic Syndromes/*therapy
Adolescent ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Male ; Retrospective Studies ; Transplantation Conditioning/adverse effects ; Transplantation Conditioning/methods ; Whole-Body Irradiation/adverse effects ; Whole-Body Irradiation/methods
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Donor-transmitted extramedullary acute myeloid leukaemia after living donor kidney transplantation.
Autorzy :: Ghandili S; Department of Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Kluger MA; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Leitner T; Department of Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Grahammer F; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Kirchner L; Department of Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Modemann F; Department of Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Mildred Scheel Cancer Career Center, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Achilles EG; Department of Visceral Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Kreipe HH; Institute of Pathology, Bone Marrow Reference Center, Hannover Medical School, Hanover, Germany.
Klein J; Institute of Human Genetics, Hannover Medical School, Hanover, Germany.
Steinemann D; Institute of Human Genetics, Hannover Medical School, Hanover, Germany.
Wolschke C; Department of Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Fischer L; Department of Visceral Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Bokemeyer C; Department of Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Fiedler W; Department of Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Huber TB; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Alsdorf WH; Department of Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Mahmud M; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Pokaż więcej
Źródło :: British journal of haematology [Br J Haematol] 2022 Jul; Vol. 198 (1), pp. 199-202. Date of Electronic Publication: 2022 Apr 15.
Typ publikacji :: Letter
MeSH Terms :: Hematopoietic Stem Cell Transplantation*
Kidney Transplantation*/adverse effects
Leukemia, Myeloid, Acute*/etiology
Leukemia, Myeloid, Acute*/therapy
Sarcoma, Myeloid*
Bone Marrow Transplantation ; Humans ; Living Donors
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Transplantation Tolerance through Hematopoietic Chimerism.
Autorzy :: Spitzer TR; From the Departments of Medicine (T.R.S.) and Surgery (D.H.S.), Massachusetts General Hospital, Boston; and the Departments of Medicine and Surgery, Columbia University, New York (D.H.S.).
Sachs DH; From the Departments of Medicine (T.R.S.) and Surgery (D.H.S.), Massachusetts General Hospital, Boston; and the Departments of Medicine and Surgery, Columbia University, New York (D.H.S.).; Pokaż więcej
Źródło :: The New England journal of medicine [N Engl J Med] 2022 Jun 16; Vol. 386 (24), pp. 2332-2333.
Typ publikacji :: Editorial; Comment
MeSH Terms :: Hematopoietic Stem Cell Transplantation*
Transplantation Chimera*/immunology
Transplantation Tolerance*/immunology
Bone Marrow Transplantation ; Chimerism ; Humans ; Transplantation Conditioning/methods
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Long-Term Incidence of Varicella Zoster Virus Disease in Adults Receiving Single-Unit Cord Blood Transplantation.
Autorzy :: Fukushi K; Department of Pharmacy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Konuma T; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Electronic address: .
Monna-Oiwa M; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Isobe M; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Kato S; Division of Clinical Precision Research Platform, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Kuroda S; Department of Pharmacy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Takahashi S; Division of Clinical Precision Research Platform, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Nannya Y; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Pokaż więcej
Źródło :: Transplantation and cellular therapy [Transplant Cell Ther] 2022 Jun; Vol. 28 (6), pp. 339.e1-339.e7. Date of Electronic Publication: 2022 Mar 29.
Typ publikacji :: Journal Article
MeSH Terms :: Cord Blood Stem Cell Transplantation*/adverse effects
Hematopoietic Stem Cell Transplantation*/adverse effects
Herpes Zoster*/epidemiology
Acyclovir/pharmacology ; Adult ; Antiviral Agents/therapeutic use ; Herpesvirus 3, Human ; Humans ; Incidence ; Retrospective Studies ; Transplantation, Homologous/adverse effects ; Virus Activation
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Measuring success in pig to non-human-primate renal xenotransplantation: Systematic review and comparative outcomes analysis of 1051 life-sustaining NHP renal allo- and xeno-transplants.
Autorzy :: Firl DJ; Center for Transplantation Sciences, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Surgery, Duke University Hospital, Durham, North Carolina, USA.
Markmann JF; Center for Transplantation Sciences, Massachusetts General Hospital, Boston, Massachusetts, USA.; Pokaż więcej
Źródło :: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2022 Jun; Vol. 22 (6), pp. 1527-1536. Date of Electronic Publication: 2022 Feb 28.
Typ publikacji :: Journal Article; Systematic Review
MeSH Terms :: Kidney Transplantation*/adverse effects
Kidney Transplantation*/methods
Transplants*
Animals ; Graft Rejection/etiology ; Graft Survival ; Heterografts ; Humans ; Macaca mulatta ; Swine ; Transplantation, Heterologous/adverse effects ; Transplantation, Heterologous/methods
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Unresolved issues in allogeneic hematopoietic cell transplantation for non-malignant diseases.
Autorzy :: Umeda K; Department of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. .; Pokaż więcej
Źródło :: International journal of hematology [Int J Hematol] 2022 Jul; Vol. 116 (1), pp. 41-47. Date of Electronic Publication: 2022 May 14.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Graft vs Host Disease*/etiology
Graft vs Host Disease*/prevention & control
Hematologic Neoplasms*/complications
Hematopoietic Stem Cell Transplantation*/adverse effects
Humans ; Quality of Life ; Transplantation Conditioning/adverse effects ; Transplantation, Homologous/adverse effects
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell Lymphoma.
Autorzy :: Kaddu-Mulindwa D; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Germany. Electronic address: .
Gödel P; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne Essen Lymphoma Working Group.
Kutsch N; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne Essen Lymphoma Working Group.
Heger JM; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne Essen Lymphoma Working Group.
Scheid C; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne Essen Lymphoma Working Group.
Borchmann P; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne Essen Lymphoma Working Group.
Holtick U; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne Essen Lymphoma Working Group.
Held G; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Germany.
Thurner L; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Germany.
Bewarder M; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Germany.
Rixecker T; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Germany.
Bittenbring JT; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Germany; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Germany.; Pokaż więcej
Źródło :: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2022 Jul; Vol. 22 (7), pp. e498-e506. Date of Electronic Publication: 2022 Jan 13.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Hematopoietic Stem Cell Transplantation*/methods
Lymphoma*/drug therapy
Lymphoma, B-Cell*/drug therapy
Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Consolidation Chemotherapy ; Humans ; Melphalan/therapeutic use ; Neoplasm Recurrence, Local/drug therapy ; Retrospective Studies ; Salvage Therapy/methods ; Stem Cell Transplantation ; Transplantation, Autologous
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: [Strategy Optimization and Clinical Analyze of Multiple Nucleotide Polymorphism Analysis in the Chimerism Detection after Allogeneic Hematopoietic Stem Cell Transplantation].
Autorzy :: Zou Z; Central Laboratory, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, Henan Province, China.
Sun R; Central Laboratory, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, Henan Province, China.
Li YW; Central Laboratory, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, Henan Province, China.
Guo Z; Central Laboratory, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, Henan Province, China.
Fan RH; Central Laboratory, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, Henan Province, China.
Lyu XD; Central Laboratory, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, Henan Province, China,E-mail：.; Pokaż więcej
Źródło :: Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2022 Jun; Vol. 30 (3), pp. 913-918.
Typ publikacji :: Journal Article
MeSH Terms :: Chimerism*
Hematopoietic Stem Cell Transplantation*
Humans ; Nucleotides ; Reproducibility of Results ; Retrospective Studies ; Transplantation Chimera/genetics ; Transplantation, Homologous
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Journey of a Patient With Multiple Myeloma Undergoing Autologous Stem Cell Transplantation.
Autorzy :: Chong CY; City of Hope National Medical Center.; Pokaż więcej
Źródło :: Clinical journal of oncology nursing [Clin J Oncol Nurs] 2022 Jun 01; Vol. 26 (3), pp. 252-256.
Typ publikacji :: Journal Article
MeSH Terms :: Hematopoietic Stem Cell Transplantation*
Multiple Myeloma*/drug therapy
Humans ; Stem Cell Transplantation ; Transplantation, Autologous
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma.
Autorzy :: Chu TH; BioMedical Sciences Graduate Program, Chonnam National University, Gwangju, Republic of Korea.; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital and Chonnam National University Medical School, 322 Seoyangro, Hwasun, Jeollanamdo, Seoul, 58128, Republic of Korea.
Jung SH; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital and Chonnam National University Medical School, 322 Seoyangro, Hwasun, Jeollanamdo, Seoul, 58128, Republic of Korea.
Kim K; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Lee JH; Gachon University Gil Medical Center, Incheon, Republic of Korea.
Mun YC; Ewha Womans University School of Medicine, Seoul, Republic of Korea.
Bang SM; Seoul National University Bundang Hospital, Seoul, Republic of Korea.
Yoon DH; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Lee HS; Kosin University Gospel Hospital, Busan, Republic of Korea.
Min CK; Department of Hematology, College of Medicine, Seoul St. Mary's Hematology Hospital, The Catholic University of Korea, 222 Banpodaero, Seocho-gu, Seoul, 137-070, Republic of Korea. .
Lee JJ; BioMedical Sciences Graduate Program, Chonnam National University, Gwangju, Republic of Korea. .; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital and Chonnam National University Medical School, 322 Seoyangro, Hwasun, Jeollanamdo, Seoul, 58128, Republic of Korea. .; Pokaż więcej
Źródło :: Annals of hematology [Ann Hematol] 2022 Jun; Vol. 101 (6), pp. 1217-1226. Date of Electronic Publication: 2022 Apr 21.
Typ publikacji :: Journal Article
MeSH Terms :: Hematopoietic Stem Cell Transplantation*
Multiple Myeloma*
Plasmacytoma*/therapy
Humans ; Neoplasm Recurrence, Local/therapy ; Retrospective Studies ; Stem Cell Transplantation ; Transplantation, Autologous
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Salvage Cord Blood Transplantation Using a Short-term Reduced-intensity Conditioning Regimen for Graft Failure.
Autorzy :: Suma S; Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Japan.
Yokoyama Y; Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan.; Department of Hematology, University of Tsukuba Hospital, Japan.
Momose H; Department of Hematology, University of Tsukuba Hospital, Japan.
Makishima K; Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Japan.
Kiyoki Y; Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Japan.
Sakamoto T; Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan.; Department of Hematology, University of Tsukuba Hospital, Japan.
Kusakabe M; Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan.; Department of Hematology, University of Tsukuba Hospital, Japan.
Kato T; Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan.; Department of Hematology, University of Tsukuba Hospital, Japan.
Kurita N; Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan.; Department of Hematology, University of Tsukuba Hospital, Japan.
Nishikii H; Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan.; Department of Hematology, University of Tsukuba Hospital, Japan.
Sakata-Yanagimoto M; Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan.; Department of Hematology, University of Tsukuba Hospital, Japan.
Obara N; Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan.; Department of Hematology, University of Tsukuba Hospital, Japan.
Hasegawa Y; Department of Hematology, Ibaraki Prefecture Central Hospital, Japan.
Chiba S; Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan.; Department of Hematology, University of Tsukuba Hospital, Japan.; Pokaż więcej
Źródło :: Internal medicine (Tokyo, Japan) [Intern Med] 2022 Jun 01; Vol. 61 (11), pp. 1673-1679. Date of Electronic Publication: 2021 Nov 20.
Typ publikacji :: Journal Article
MeSH Terms :: Cord Blood Stem Cell Transplantation*
Graft vs Host Disease*/etiology
Hematopoietic Stem Cell Transplantation*/adverse effects
Humans ; Retrospective Studies ; Salvage Therapy/methods ; Transplantation Conditioning/methods ; Vidarabine/therapeutic use
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Variable impact of graft CD3 cells overestimated?
Autorzy :: Yegin ZA; Gazi University Faculty of Medicine, Department of Hematology, Ankara, Turkey. Electronic address: .
Bostankolu Değirmenci B; Gazi University Faculty of Medicine, Department of Hematology, Ankara, Turkey.
Yazıcı Şener G; Gazi University Faculty of Medicine, Department of Internal Medicine, Ankara, Turkey.
Savaş EM; Gazi University Faculty of Medicine, Department of Hematology, Ankara, Turkey.
Özkurt ZN; Gazi University Faculty of Medicine, Department of Hematology, Ankara, Turkey.
Koç HN; Gazi University Faculty of Medicine, Department of Internal Medicine, Ankara, Turkey.
İlhan Ç; Gazi University Faculty of Medicine, Department of Hematology, Ankara, Turkey.; Pokaż więcej
Źródło :: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis [Transfus Apher Sci] 2022 Jun; Vol. 61 (3), pp. 103349. Date of Electronic Publication: 2021 Dec 29.
Typ publikacji :: Journal Article
MeSH Terms :: Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation*/adverse effects
Adult ; Female ; Humans ; Male ; Recurrence ; Retrospective Studies ; Transplantation Conditioning/adverse effects ; Transplantation, Homologous/adverse effects
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Current Status and Perspectives of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia.
Autorzy :: Sophie S; Department of Clinical Hematology, CHU of Liège, Liège, Belgium.; Hematology Research Unit GIGA-I3, University of Liège, Liège, Belgium.
Yves B; Department of Clinical Hematology, CHU of Liège, Liège, Belgium.; Hematology Research Unit GIGA-I3, University of Liège, Liège, Belgium.
Frédéric B; Department of Clinical Hematology, CHU of Liège, Liège, Belgium.; Hematology Research Unit GIGA-I3, University of Liège, Liège, Belgium.; Pokaż więcej
Źródło :: Stem cells translational medicine [Stem Cells Transl Med] 2022 May 27; Vol. 11 (5), pp. 461-477.
Typ publikacji :: Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms :: Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation*
Leukemia, Myeloid, Acute*/therapy
Aged ; Humans ; Transplantation Conditioning ; Transplantation, Homologous
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Impact of risk scores in outcome of patients with myeloid neoplasms after allogeneic stem cell transplant.
Autorzy :: Fernández-Caballero M; Servicio de Hematología, Institut Català d'Oncologia, Institut de Recerca contra la Leucèmia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain. Electronic address: .
Jiménez Lorenzo MJ; Servicio de Hematología, Institut Català d'Oncologia, Institut de Recerca contra la Leucèmia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
Morgades de la Fe M; Servicio de Hematología, Institut Català d'Oncologia, Institut de Recerca contra la Leucèmia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
Ferrà Coll C; Servicio de Hematología, Institut Català d'Oncologia, Institut de Recerca contra la Leucèmia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
Vives Polo S; Servicio de Hematología, Institut Català d'Oncologia, Institut de Recerca contra la Leucèmia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
Abril Sabater L; Servicio de Hematología, Institut Català d'Oncologia, Institut de Recerca contra la Leucèmia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
Navarro Ferrando JT; Servicio de Hematología, Institut Català d'Oncologia, Institut de Recerca contra la Leucèmia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
Ribera Santasusana JM; Servicio de Hematología, Institut Català d'Oncologia, Institut de Recerca contra la Leucèmia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.; Pokaż więcej
Źródło :: Medicina clinica [Med Clin (Barc)] 2022 May 27; Vol. 158 (10), pp. 451-457. Date of Electronic Publication: 2021 Aug 14.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Hematopoietic Stem Cell Transplantation*
Leukemia, Myeloid, Acute*/therapy
Myelodysplastic Syndromes*/therapy
Myeloproliferative Disorders*
Humans ; Recurrence ; Retrospective Studies ; Risk Factors ; Transplantation Conditioning ; Transplantation, Homologous
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Outcomes linked to eligibility for stem cell transplantation trials in diffuse cutaneous systemic sclerosis.
Autorzy :: Spierings J; Division of Medicine, Department of Inflammation, Centre for Rheumatology and Connective Tissue Diseases, Royal Free and University College Medical School, University College London, London, UK.; Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Nihtyanova SI; Division of Medicine, Department of Inflammation, Centre for Rheumatology and Connective Tissue Diseases, Royal Free and University College Medical School, University College London, London, UK.
Derrett-Smith E; Division of Medicine, Department of Inflammation, Centre for Rheumatology and Connective Tissue Diseases, Royal Free and University College Medical School, University College London, London, UK.
Clark KEN; Division of Medicine, Department of Inflammation, Centre for Rheumatology and Connective Tissue Diseases, Royal Free and University College Medical School, University College London, London, UK.
van Laar JM; Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Ong V; Division of Medicine, Department of Inflammation, Centre for Rheumatology and Connective Tissue Diseases, Royal Free and University College Medical School, University College London, London, UK.
Denton CP; Division of Medicine, Department of Inflammation, Centre for Rheumatology and Connective Tissue Diseases, Royal Free and University College Medical School, University College London, London, UK.; Pokaż więcej
Źródło :: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2022 May 05; Vol. 61 (5), pp. 1948-1956.
Typ publikacji :: Journal Article
MeSH Terms :: Hematopoietic Stem Cell Transplantation*
Hypertension, Pulmonary*/etiology
Scleroderma, Diffuse*/drug therapy
Scleroderma, Systemic*/drug therapy
Aged ; Dihydrotachysterol/therapeutic use ; Humans ; Male ; Stem Cell Transplantation ; Transplantation, Autologous
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Differences in Protein Secretion by Multipotent Mesenchymal Stromal Cells Effective and Ineffective in the Prevention of Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Autorzy :: Petinati NA; National Medical Research Center of Hematology, Ministry of Health of the Russian Federation, Moscow, Russia. .
Drize NI; National Medical Research Center of Hematology, Ministry of Health of the Russian Federation, Moscow, Russia.
Arapidi GP; National Medical Research Center of Hematology, Ministry of Health of the Russian Federation, Moscow, Russia.
Shender VO; National Medical Research Center of Hematology, Ministry of Health of the Russian Federation, Moscow, Russia.
Lagar'kova MA; National Medical Research Center of Hematology, Ministry of Health of the Russian Federation, Moscow, Russia.
Kuz'mina LA; National Medical Research Center of Hematology, Ministry of Health of the Russian Federation, Moscow, Russia.
Parovichnikova EN; National Medical Research Center of Hematology, Ministry of Health of the Russian Federation, Moscow, Russia.
Savchenko VG; National Medical Research Center of Hematology, Ministry of Health of the Russian Federation, Moscow, Russia.; Pokaż więcej
Źródło :: Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2022 May; Vol. 173 (1), pp. 128-132. Date of Electronic Publication: 2022 May 27.
Typ publikacji :: Journal Article
MeSH Terms :: Graft vs Host Disease*/prevention & control
Hematopoietic Stem Cell Transplantation*/adverse effects
Mesenchymal Stem Cell Transplantation*
Mesenchymal Stem Cells*
Humans ; Transplantation, Homologous
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Improving allogeneic stem cell transplantation in myelofibrosis.
Autorzy :: Gagelmann N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistr 52, 20246, Hamburg, Germany.
Kröger N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistr 52, 20246, Hamburg, Germany. .; Pokaż więcej
Źródło :: International journal of hematology [Int J Hematol] 2022 May; Vol. 115 (5), pp. 619-625. Date of Electronic Publication: 2022 Apr 13.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Hematologic Neoplasms*/etiology
Hematopoietic Stem Cell Transplantation*/adverse effects
Primary Myelofibrosis*/genetics
Primary Myelofibrosis*/therapy
Humans ; Neoplasm Recurrence, Local/etiology ; Transplantation Conditioning/methods ; Transplantation, Homologous
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Improving Safety and Outcomes After Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience.
Autorzy :: Salas MQ; Department of Medicine, University of Toronto, Toronto, Canada; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network. Toronto, Canada; Bone Marrow Transplant Unit, Department of Hematology, IDIBAPS, Hospital Clinic de Barcelona, Spain.
Pasic I; Department of Medicine, University of Toronto, Toronto, Canada; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network. Toronto, Canada.
Remberger M; Department of Medical Sciences, Uppsala University and KFUE, Uppsala University Hospital, Uppsala, Sweden.
Novitzky-Basso I; Department of Medicine, University of Toronto, Toronto, Canada; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network. Toronto, Canada.
Law AD; Department of Medicine, University of Toronto, Toronto, Canada; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network. Toronto, Canada.
Lam W; Department of Medicine, University of Toronto, Toronto, Canada; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network. Toronto, Canada.
Chen C; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network. Toronto, Canada.
Kim DDH; Department of Medicine, University of Toronto, Toronto, Canada; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network. Toronto, Canada.
Michelis FV; Department of Medicine, University of Toronto, Toronto, Canada; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network. Toronto, Canada.
Gerbitz A; Department of Medicine, University of Toronto, Toronto, Canada; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network. Toronto, Canada.
Viswabandya A; Department of Medicine, University of Toronto, Toronto, Canada; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network. Toronto, Canada.
Lipton JH; Department of Medicine, University of Toronto, Toronto, Canada; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network. Toronto, Canada.
Kumar R; Department of Medicine, University of Toronto, Toronto, Canada; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network. Toronto, Canada.
Mattsson J; Department of Medicine, University of Toronto, Toronto, Canada; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network. Toronto, Canada; Gloria and Seymour Epstein Chair in Cell Therapy and Transplantation, Department of Medicine, University of Toronto, Toronto, Canada. Electronic address: .; Pokaż więcej
Źródło :: Transplantation and cellular therapy [Transplant Cell Ther] 2022 May; Vol. 28 (5), pp. 265.e1-265.e9. Date of Electronic Publication: 2022 Feb 06.
Typ publikacji :: Journal Article
MeSH Terms :: Graft vs Host Disease*/prevention & control
Hematopoietic Stem Cell Transplantation*/adverse effects
Adult ; Antilymphocyte Serum/therapeutic use ; Cyclosporine/therapeutic use ; Humans ; Transplantation Conditioning/adverse effects ; Transplantation, Homologous/adverse effects
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Total body irradiation-based versus busulfan-based myeloablative conditioning for single-unit cord blood transplantation in adults.
Autorzy :: Konuma T; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Ooi J; Department of Health and Nutrition, University of Human Arts and Sciences, Saitama, Japan.
Monna-Oiwa M; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Isobe M; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Tomonari A; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Kato S; Department of Hematology, Yokohama Minami Kyousai Hospital, Yokohama, Japan.
Iseki T; Department of Transfusion Medicine and Cell Therapy, Chiba University Hospital, Chiba, Japan.
Nannya Y; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Tojo A; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Takahashi S; Division of Clinical Precision Research Platform, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Pokaż więcej
Źródło :: Leukemia & lymphoma [Leuk Lymphoma] 2022 May; Vol. 63 (5), pp. 1191-1201. Date of Electronic Publication: 2021 Dec 23.
Typ publikacji :: Journal Article
MeSH Terms :: Cord Blood Stem Cell Transplantation*/adverse effects
Cord Blood Stem Cell Transplantation*/methods
Graft vs Host Disease*/etiology
Graft vs Host Disease*/prevention & control
Hematopoietic Stem Cell Transplantation*
Adult ; Busulfan/therapeutic use ; Humans ; Myeloablative Agonists/therapeutic use ; Retrospective Studies ; Transplantation Conditioning/methods ; Whole-Body Irradiation
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Oral chronic GVHD after allogeneic stem cell transplantation without total body irradiation performed at a young age.
Autorzy :: Tanem KE; Department of Oral Surgery and Oral Medicine, Faculty of Dentistry, University of Oslo, Postbox 1109 Blindern, N-0317, Oslo, Norway. .
Wilberg P; Department of Oral Surgery and Oral Medicine, Faculty of Dentistry, University of Oslo, Postbox 1109 Blindern, N-0317, Oslo, Norway.
Diep PP; Department of Pediatric Oncology and Hematology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Ruud E; Department of Pediatric Oncology and Hematology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Skaare AB; Department of Pediatric Dentistry and Behavioral Science, Faculty of Dentistry, University of Oslo, Oslo, Norway.
Brinch L; Department of Hematology, Oslo University Hospital, Oslo, Norway.
Herlofson BB; Department of Oral Surgery and Oral Medicine, Faculty of Dentistry, University of Oslo, Postbox 1109 Blindern, N-0317, Oslo, Norway.; Unit of Oral and Maxillofacial Surgery, Division for Head, Neck, and Reconstructive Surgery, Department of Otorhinolaryngology, Oslo University Hospital, Oslo, Norway.; Pokaż więcej
Źródło :: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2022 May; Vol. 30 (5), pp. 4121-4128. Date of Electronic Publication: 2022 Jan 24.
Typ publikacji :: Journal Article
MeSH Terms :: Graft vs Host Disease*/pathology
Hematopoietic Stem Cell Transplantation*/adverse effects
Adolescent ; Adult ; Child ; Child, Preschool ; Chronic Disease ; Humans ; Infant ; Survivors ; Transplantation Conditioning/adverse effects ; Transplantation, Homologous/adverse effects ; Whole-Body Irradiation/adverse effects ; Young Adult
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Transplantation"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Starter badań:

Transplantation.